Auto saved by Logseq

master
Borja Robert 11 months ago
parent b79b168474
commit 2b53cccfb4

@ -87,4 +87,7 @@
- Especificar que la novel formulation es una fixed-dose coformulation de [[Ivermectina]] y [[Albendazol]].
- Especificar que esta fixed-dose coformulation de ivm/alb has the lowest [[level]] of investment risk of all candidates for Combinations for [[STH]] treatment (fuente: Soil Transmitted Helminths Drug Combinations Expert Meeting, 2016, Gates Foundation)
- Una referencia explícita al Estudio ALIVE: https://gatesopenresearch.org/articles/6-62/v1
- Los achievements de los STOP previos
- Qualification at EMA for [[article]] 58 (ahora se llama Meds4All, creo)
- Proved safety
-
Loading…
Cancel
Save